N-(4-甲基-3-硝基苯基)乙酰胺 | 2719-14-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: N-(4-甲基-3-硝基苯基)乙酰胺
• 中文别名: 4'-甲基-间硝基乙酰替苯胺；4-甲基-3-硝基乙酰苯胺；N-(4 - 甲基-3 - 硝基苯基)乙酰胺
• 英文名称: 4-acetylamino-2-nitrotoluene
• 英文别名: 4'-methyl-3'-nitroacetanilide；2-nitro-4-acetylaminotoluene；N-(4-methyl-3-nitro-phenyl)acetamide；N-(4-Methyl-3-nitrophenyl)acetamide
• CAS: 2719-14-4
• 化学式: C₉H₁₀N₂O₃
• mdl: MFCD00024277
• 分子量: 194.19
• InChiKey: XYTSBFSNPUGBIH-UHFFFAOYSA-N

物化性质

• 熔点：
  100-100.5°C
• 沸点：
  370.0±30.0 °C(Predicted)
• 密度：
  1.289±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  74.9
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2921420090
• 危险性防范说明：
  P261,P264,P270,P271,P280,P301+P312,P302+P352,P304+P340,P305+P351+P338,P330,P332+P313,P337+P313,P362,P403+P233,P405,P501
• 危险性描述：
  H315,H319,H335

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : 4'-METHYL-3'-NITROACETANILIDE
CAS-No. : 2719-14-4
Relevant identified uses of the substance or mixture and uses advised against
Identified uses : Laboratory chemicals, Manufacture of substances

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
This substance is not classified as dangerous according to Directive 67/548/EEC.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C9H10N2O3
Molecular Weight : 194,19 g/mol
Component Concentration
4'-METHYL-3'-NITROACETANILIDE
CAS-No. 2719-14-4 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIRE-FIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Avoid
breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end uses
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and at
the end of workday.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and the
standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 0,748
octanol/water
p) Autoignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes
May cause eye irritation.
Signs and Symptoms of Exposure
To the best of our knowledge, the chemical, physical, and toxicological properties have not been thoroughly
investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment
no data available

---

Section 16. OTHER INFORMATION
Further information
Copyright 2011 Co. License granted to make unlimited paper copies for internal use only.
The above information is believed to be correct but does not purport to be all inclusive and shall be used
only as a guide. The information in this document is based on the present state of our knowledge and is
applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Co., shall not be held liable for any damage
resulting from handling or from contact with the above product. See reverse side of invoice or packing slip
for additional terms and conditions of sale.

反应信息

• 作为反应物：
  描述：

  N-(4-甲基-3-硝基苯基)乙酰胺 在 过氧单硫酸 、 硫酸 、 potassium nitrate 作用下， 生成 1-甲基-2,3,4-三硝基苯
  参考文献：
  名称：

  Scott; Robinson, Journal of the Chemical Society, 1922, vol. 121, p. 845

  摘要：

  DOI：
• 作为产物：
  描述：

  4-甲基乙酰苯胺 在 sodium nitrate 、 硫酸 作用下， 反应 3.0h， 以94%的产率得到N-(4-甲基-3-硝基苯基)乙酰胺
  参考文献：
  名称：

  Rosevear, Judi; Wilshire, John F. K., Australian Journal of Chemistry, 1985, vol. 38, # 5, p. 723 - 733

  摘要：

  DOI：

文献信息

• Werner transition-metal complex (WTMC)-mediated mild and efficient chemo-selective acylation of phenols and anilines under solvent-free condition
  作者：Abdulla Sarief、SK Manirul Haque、Syed Mudabbir Feroze、Mohammed Arifuddin

  DOI：10.1002/jccs.201800013

  日期：2018.9

  Werner‐type transition‐metal complexes (WTMC) such as [Co(NH3)5Cl]Cl2, Cu[(NH3)4]SO4, Mn(acac)3, Ni[(NH3)6]Cl2, Ni[(en)3]S2O3, and Hg[Co(SCN)4] efficiently promote the chemoselective acetylation of phenols and anilines under solvent‐free condition. The results of this study clearly shows that the optimal condition for the acetylation of anilines/phenols (1 mmol) (2a–r) with acetic anhydride (1.2 mmol)

  Werner型过渡金属络合物（WTMC），例如[Co（NH 3）5 Cl] Cl 2，Cu [（NH 3）4 ] SO 4，Mn（acac）3，Ni [（NH 3）6 ] Cl 2，Ni [（en）3 ] S 2 O 3和Hg [Co（SCN）4 ]在无溶剂条件下有效地促进了苯酚和苯胺的化学选择性乙酰化。这项研究的结果清楚地表明，在存在WTMC（1 mmol）和两滴H的条件下，用乙酸酐（1.2 mmol）乙酰苯胺/苯酚（1 mmol）（2a–r）进行乙酰化的最佳条件在无溶剂条件下加热10分钟可得到3 PO 4，其相应的乙酰苯胺/乙酸苯酯（3a–r）良好或优异。此外，该方法简便，高效，化学选择性且在无溶剂条件下对生态环境友好，用于使用无水乙酸作为乙酰化剂，WTMC促进的苯胺和苯酚的乙酰化。催化剂的简单制备，乙酰化反应的简便程序以及简单的后处理都表明了WTMC对于此类反应的重要性。
• Retinoid-like compounds
  申请人：Bristol-Myers Squibb Company

  公开号：US05618839A1

  公开（公告）日：1997-04-08

  The present invention relates to a compound of formula I ##STR1## or a nontoxic pharmaceutically acceptable salt, physiologically hydrolyzable ester or solvate thereof, in which X is --O--CO--, --NH--CO--, --CS--NH--, --CO--O--, --CO--NH--, --COS--, --SCO--, --SCH.sub.2 --, --CH.sub.2 --CH.sub.2 --, --C.tbd.C--, --CH.sub.2 --NH--, --COCH.sub.2 --, --NHCS--, --CH.sub.2 S--, --CH.sub.2 O--, --OCH.sub.2 --, --NHCH.sub.2 -- or --CR.sup.5 .dbd.CR.sup.6 --; R.sup.m and R.sup.k are independently hydrogen, halogen, C.sub.1-6 alkyl, hydroxy, C.sub.1-6 alkyloxy or nitro; n is zero or one; R.sup.4 is --(CH.sub.2).sub.t --Y, C.sub.1-6 alkyl, or C.sub.3-6 cycloalkyl; R.sup.1 is --CO.sub.2 Z, C.sub.1-6 alkyl, CH.sub.2 OH, --CONHR.sup.y, or CHO; R.sup.2 and R.sup.3 are independently hydrogen or C.sub.1-6 alkyl; R.sup.a and R.sup.b are independently hydrogen or C.sub.1-6 alkyl; but when n is one, R.sup.a and R.sup.b together can form a radical of the formula ##STR2## Y is naphthyl or phenyl, both radicals can be optionally substituted with one to three same or different C.sub.1-6 alkyl or halogen; Z is hydrogen or C.sub.1-6 alkyl; R.sup.5, R.sup.6 and R.sup.y are independently hydrogen or C.sub.1-6 alkyl; and t is zero to six.

  该发明涉及式I的化合物##STR1##或其无毒的药学上可接受的盐、生理可水解的酯或溶剂化合物，其中X为--O--CO--、--NH--CO--、--CS--NH--、--CO--O--、--CO--NH--、--COS--、--SCO--、--SCH.sub.2--、--CH.sub.2--CH.sub.2--、--C.tbd.C--、--CH.sub.2--NH--、--COCH.sub.2--、--NHCS--、--CH.sub.2S--、--CH.sub.2O--、--OCH.sub.2--、--NHCH.sub.2--或--CR.sup.5.dbd.CR.sup.6--; R.sup.m和R.sup.k独立地为氢、卤素、C.sub.1-6烷基、羟基、C.sub.1-6烷氧基或硝基；n为零或一；R.sup.4为--(CH.sub.2).sub.t--Y、C.sub.1-6烷基或C.sub.3-6环烷基；R.sup.1为--CO.sub.2Z、C.sub.1-6烷基、CH.sub.2OH、--CONHR.sup.y或CHO；R.sup.2和R.sup.3独立地为氢或C.sub.1-6烷基；R.sup.a和R.sup.b独立地为氢或C.sub.1-6烷基；但当n为一时，R.sup.a和R.sup.b可以共同形成式的基团##STR2##Y为萘基或苯基，两个基团可以选择性地用一个到三个相同或不同的C.sub.1-6烷基或卤素取代；Z为氢或C.sub.1-6烷基；R.sup.5、R.sup.6和R.sup.y独立地为氢或C.sub.1-6烷基；t为零到六。
• Benzyl-piperidine derivatives
  申请人：Hoffmann-La Roche Inc.

  公开号：US05753679A1

  公开（公告）日：1998-05-19

  Benzly-piperidine derivatives of formula I and their pharmaceutically acceptable salts are used in the control of psychotic disorders which are caused by damage to the dopamine system, especially schizophrenia. ##STR1## A is ##STR2## B is ##STR3## R.sup.1, R.sup.2 and R.sup.3 are independently hydrogen, amino, nitro, halogen, lower-alkly or lower-alkoxy. R.sup.4, R.sup.5 and R.sup.6 are independently hydrogen, nitro, halogen, lower-alkyl, lower-alkoxy, cyano, trifluoromethyl, amino, lower-alkylamino or di-lower-alkylamino. R.sup.7, R.sup.2 and R.sup.9 are independently hydrogen, amino or nitro.

  Benzly-哌啶I类衍生物及其药学上可接受的盐用于控制由多巴胺系统损伤引起的精神障碍，尤其是精神分裂症。 ##STR1## A为 ##STR2## B为 ##STR3## R.sup.1、R.sup.2和R.sup.3各自独立地为氢、氨基、硝基、卤素、低级烷基或低级烷氧基。 R.sup.4、R.sup.5和R.sup.6各自独立地为氢、硝基、卤素、低级烷基、低级烷氧基、氰基、三氟甲基、氨基、低级烷基氨基或二低级烷基氨基。 R.sup.7、R.sup.2和R.sup.9各自独立地为氢、氨基或硝基。
• Functionalization of Quinazolin-4-ones Part 1: Synthesis of Novel 7-Substituted-2-thioxo Quinazolin-4-ones from 4-Substituted-2-Aminobenzoic Acids and PPh₃(SCN)₂
  作者：Jacob Heppell、Jasim Al-Rawi

  DOI：10.1002/jhet.1669

  日期：2014.1

  acetylamino)‐2‐aminobenzoic acid were allowed to react with PPh3(SCN)2 and gave the crossholding 7‐nitro, 7‐acetylamino‐ and 7‐amino‐2‐thioxo quinazolin‐4‐ones respectively. The nature of the substituent at position 4 of the 2‐aminobenzoic acids has significant influence on the outcome of the cyclisation reaction with PPh3(SCN)2. Similarly, the nature of the substituent at position 7 of the 2‐substituted

  允许4-（硝基，氨基，乙酰氨基）-2-氨基苯甲酸与PPh 3（SCN）2反应并生成交联的7-硝基，7-乙酰氨基和7-氨基-2-硫代喹唑啉-4-酮分别。2-氨基苯甲酸第4位的取代基的性质对与PPh 3（SCN）2的环化反应的结果有重大影响。同样，在2-取代的喹唑啉-4-酮的7位上的取代基的性质显着影响了烷基化反应的难易程度。发现7-取代2-巯基喹唑啉-4-酮的烷基化选择性取决于卤代烷的性质和2位取代基的性质。
• A SIMPLE AND EFFICIENT PROCEDURE FOR THE BECKMANN REARRANGEMENT OF OXIME USING<i>bis</i>-(TRICHLOROMETHYL) CARBONATE/DMF
  作者：W. K. Su、Y. Zhang、J. J. Li、P. Li

  DOI：10.1080/00304940809458118

  日期：2008.12

  also be used for the Beckmann rearrangement with satisfactory results under mild conditions (Scheme 1). Jochims et al." have reported that oximes react with oxalyl chloride in the presence of Lewis acid to give nitrilium salts which then rearrange. Compared with this method, our procedure is much easier to control and more environmentally friendly. Acetophenone oxime (mixture of E/Z isomers) was used

  酮肟贝克曼重排为酰胺是有机合成和化学制造中的有效方法；' 该反应通常需要高温和大量的强布朗斯台德酸。因此，人们寻求温和的条件，并报告了使用超临界水的程序：气相过程？和离子液体！但是，这些方法有很多限制。例如，超临界水不能广泛使用，气相反应通常需要较高的反应温度。因此，使用敏感基材通常是不可能的。尽管在离子液体中反应条件通常温和，但一些试剂非常昂贵。因此，发展绿色、用于贝克曼重排的简单且具有成本效益的催化系统的需求量很大。双（三氯甲基）碳酸酯（BTC，三光气）已成为合成某些重要有机化合物的通用助剂？与光气相比，它的使用已被证明是安全和有利的。由 DMF 和 POC1 生成的 Vilsmeier 试剂 (PCI,, P,O,) 已广泛用于酰化、氯化、氯甲酰化、芳构化、环化等 3.6 作为我们正在进行的 Vilsmeier 试剂开发计划的一部分使用 BTC/DMF？我们发现这种类型的 Vilsmeier